Access cutting-edge urothelial cancer treatment through this clinical trial at a research site in Kingman. Study-provided care at no cost to qualified participants.
Access urothelial cancer specialists in Kingman at no cost
This study follows strict safety protocols and ethical guidelines
All study-related urothelial cancer treatment provided free
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This tri
Sponsor: National Cancer Institute (NCI)
Check if you qualify for this urothelial cancer clinical trial in Kingman, AZ
If you're searching for urothelial cancer treatment options in Kingman, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kingman research site is actively enrolling participants for this clinical trial. You'll receive care from experienced urothelial cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.